Healthcare
IT budgets could shrink for half of life sciences firms
IT budgets could shrink for half of life sciences firms
Only 15% of life sciences firms believe digital tools could enhance customer experience.
Cheaper cell therapy gains ground in Australia, China, and Japan
In China, 80% of CAR-T trials are already being conducted by hospitals.
Migrant workers gain access to universal healthcare in Thailand
An estimated 1.5 million undocumented migrants registered with the Ministry of Public Health in 2018.
Top three healthcare firms in Singapore averaged total return at 31.2% in January-July 2019
These three firms’ average dividend yield came at 3.3% over the same period.
Indian drugmakers expand to China through joint ventures: report
Tight competition in the US is driving Indian pharmaceuticals east.
Buyout sought for India's Apollo Hospitals as owner seeks to pay debt
The aim is to reduce the Apollo shares pledged by the controlling family as collateral to lenders, to 20% of their total holding.
Taiwan's health ministry to greenlight cell therapies for two hospitals
Shin Kong International HealthCare Center in Taipei is likely to be approved for non-cancer related cell therapy.
Chinese healthcare revenue growth set to weaken
The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.
Genesis Healthcare launches wellness app
Users can receive lifestyle tips and health recommendations based on individual DNA.
New York-listed New Frontier to buy China's United Family Healthcare for $1.44b
UFH is expected to be given the exclusive right to manage New Frontier Group’s 64,000 sqm flagship Shenzhen city center hospital.
Temasek unit invests $5m in HC Surgical Specialists
It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.
Raffles Medical Group profits down 14.7% in H1
Operating revenue fell due to the promotion and building costs for its Chongqing hospital.
Temasek unit invests $5m in HC Surgical Specialists
It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.
Singapore's medical device market value to hit $1.3b by 2023: analyst
Increased government expenditure will support the segment.
Is it time to invest in at-home technologies for chronic disease care in Singapore?
Two in five health practitioners recommend a more integrated hospital-home care approach.
Mount Alvernia Hospital and Icon SOC partner to launch $25m integrated cancer centre
The upcoming facility is expected to start its operations in late 2020.
China's healthcare service sector's revenue to hit $1.16t by 2020
Tech giants such as Ping An and Tencent are tapping into blockchain and AI to address the sector’s talent shortage.
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Event News
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
